Skip to main content
The NCI Community Hub will be retiring in May 2024. For more information please visit the NCIHub Retirement Page:https://ncihub.cancer.gov/groups/ncihubshutdown/overview
close

Tags: Nanoparticles

More tags

Resources (61-80 of 102)

  1. NCL Method ITA-37.1

    27 Oct 2022 | Datasets | Contributor(s):

    By Hannah Newton1, Jenny Zhang2, Marina Dobrovolskaia

    1. Nanotechnology Characterization Lab 2. Agilent Technologies

    Immunophenotyping: Instrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures

    https://ncihub.cancer.gov/publications/311/?v=2

  2. NCL Method ITA-37.1

    08 Sep 2022 | Datasets | Contributor(s):

    By Hannah Newton1, Jenny Zhang2, Marina Dobrovolskaia

    1. Nanotechnology Characterization Lab 2. Agilent Technologies

    Immunophenotyping: Instrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures

    https://ncihub.cancer.gov/publications/311/?v=1

  3. NCL Method ITA-37.2

    27 Oct 2022 | Datasets | Contributor(s):

    By Hannah Newton, Jenny Zhang, Marina Dobrovolskaia

    Immunophenotyping: Analysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells

    https://ncihub.cancer.gov/publications/312/?v=2

  4. NCL Method ITA-37.2

    08 Sep 2022 | Datasets | Contributor(s):

    By Hannah Newton, Jenny Zhang, Marina Dobrovolskaia

    Immunophenotyping: Analysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells

    https://ncihub.cancer.gov/publications/312/?v=1

  5. NCL Method ITA-4

    09 Jul 2020 | Datasets | Contributor(s):

    By Barry Neun, Chris McLeland, Timothy Potter, Anna Ilinskaya, Marina Dobrovolskaia, Suzanne Specht1, Tad Guszcynski1

    Leidos Biomedical Research, Inc.

    Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE

    https://ncihub.cancer.gov/publications/137/?v=3

  6. NCL Method ITA-4

    15 Jun 2020 | Datasets | Contributor(s):

    By Barry Neun, Chris McLeland, Timothy Potter, Marina Dobrovolskaia, Suzanne Specht1, Tad Guszcynski1

    Leidos Biomedical Research, Inc.

    Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE

    https://ncihub.cancer.gov/publications/137/?v=2

  7. NCL Method ITA-4

    18 Mar 2020 | Datasets | Contributor(s):

    By Barry Neun, Chris McLeland, Timothy Potter, Anna Ilinskaya, Marina Dobrovolskaia, Suzanne Specht1, Tad Guszcynski1

    Leidos Biomedical Research, Inc.

    Analysis of Nanoparticle Interaction with Plasma Proteins by 2D PAGE

    https://ncihub.cancer.gov/publications/137/?v=1

  8. NCL Method ITA-40

    18 Oct 2022 | Datasets | Contributor(s):

    By Edward Cedrone, Martin Schuster1, Rosemarie Preyer1, Marina Dobrovolskaia

    AID Autoimmun Diagnostika GmbH

    Understanding the Role of Scavenger Receptor A1 in Nanoparticle Uptake by Murine Macrophages

    https://ncihub.cancer.gov/publications/313/?v=2

  9. NCL Method ITA-40

    08 Sep 2022 | Datasets | Contributor(s):

    By Edward Cedrone, Marina Dobrovolskaia

    Understanding the Role of Scavenger Receptor A1 in Nanoparticle Uptake by Murine Macrophages

    https://ncihub.cancer.gov/publications/313/?v=1

  10. NCL Method ITA-5.1

    18 Mar 2020 | Datasets | Contributor(s):

    By Barry Neun, Anna Ilinskaya, Marina Dobrovolskaia

    Qualitative Analysis of Total Complement Activation by Western Blot

    https://ncihub.cancer.gov/publications/138/?v=1

  11. NCL Method ITA-5.2

    09 Jul 2020 | Datasets | Contributor(s):

    By Barry Neun, Edward Cedrone, Marina Dobrovolskaia

    Analysis of Complement Activation by single-plex EIA or multiplex ELISA

    https://ncihub.cancer.gov/publications/204/?v=2

  12. NCL Method ITA-6.1

    09 Jul 2020 | Datasets | Contributor(s):

    By Timothy Potter, Edward Cedrone, Sarah Skoczen, Barry Neun, Marina Dobrovolskaia

    Leukocyte Proliferation Assay

    https://ncihub.cancer.gov/publications/205/?v=2

  13. NCL Method ITA-6.2

    09 Jul 2020 | Datasets | Contributor(s):

    By Timothy Potter, Edward Cedrone, Sarah Skoczen, Barry Neun, Marina Dobrovolskaia

    Leukocyte Proliferation Assay

    https://ncihub.cancer.gov/publications/206/?v=2

  14. NCL Method ITA-6.3

    09 Jul 2020 | Datasets | Contributor(s):

    By Timothy Potter, Edward Cedrone, Sarah Skoczen, Barry Neun, Marina Dobrovolskaia

    Leukocyte Proliferation Assay

    https://ncihub.cancer.gov/publications/207/?v=2

  15. NCL Method ITA-7

    04 Feb 2021 | Datasets | Contributor(s):

    By Timothy Potter, Edward Cedrone, Barry Neun, Marina Dobrovolskaia

    Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7

    https://ncihub.cancer.gov/publications/252/?v=1

  16. NCL Method ITA-7

    18 Mar 2020 | Datasets | Contributor(s):

    By Barry Neun, Timothy Potter, Jamie Rodriguez, Anna Ilinskaya, Marina Dobrovolskaia

    Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7

    https://ncihub.cancer.gov/publications/140/?v=1

  17. NCL Method ITA-8.1

    09 Jul 2020 | Datasets | Contributor(s):

    By Timothy Potter, Edward Cedrone, Barry Neun, Marina Dobrovolskaia

    Chemotaxis Assay

    https://ncihub.cancer.gov/publications/208/?v=2

  18. NCL Method ITA-8.2

    09 Jul 2020 | Datasets | Contributor(s):

    By Edward Cedrone, Julia Bui, Naichen Yu, Marina Dobrovolskaia

    Analysis of nanoparticle chemoattractant properties using label-free, real-time chemotaxis assay

    https://ncihub.cancer.gov/publications/209/?v=2

  19. NCL Method ITA-9

    19 Mar 2020 | Datasets | Contributor(s):

    By Timothy Potter, Sarah Skoczen, Jamie Rodriguez, Barry Neun, Anna Ilinskaya, Marina Dobrovolskaia

    Phagocytosis Assay

    https://ncihub.cancer.gov/publications/143/?v=1

  20. NCL Method ITA-9.1

    09 Jul 2020 | Datasets | Contributor(s):

    By Timothy Potter, Edward Cedrone, Barry Neun, Marina Dobrovolskaia

    Phagocytosis Assay

    https://ncihub.cancer.gov/publications/210/?v=2